BACKGROUND: Although exposure to house dust mite allergen is a major risk factor for allergic sensitization and asthma, nationwide estimates of dust mite allergen levels in US homes have not been reported. OBJECTIVE: The purpose of this study was to estimate the prevalence of dust mite allergen in beds of US homes and to identify predictors of dust mite allergen concentration. METHODS: Data were obtained from the first National Survey of Lead and Allergens in Housing, a cross-sectional survey of 831 permanently occupied noninstitutional housing units that permitted resident children. Dust mite allergen concentration (Der f 1 plus Der p 1) was determined from a dust sample collected from a bed. The percentages of homes with concentrations at or greater than detection, 2.0 microg/g bed dust, and 10.0 microg/g bed dust were estimated. Independent predictors of allergen concentration were assessed with multivariable linear regression. RESULTS: The percentages of US homes with dust mite allergen concentrations at or greater than detection, 2.0 microg/g, and 10.0 microg/g were 84.2% (SE, 1.73), 46.2% (SE, 2.0), and 24.2% (SE, 2.1), respectively. Independent predictors of higher levels were older homes, non-West census regions, single-family homes, no resident children, lower household income, heating sources other than forced air, musty or mildew odor, and higher bedroom humidity. CONCLUSION: Most US homes have detectable levels of dust mite allergen in a bed. Levels previously associated with allergic sensitization and asthma are common in US bedrooms. Predictors can be used to identify conditions under which homes are more likely to have increased dust mite allergen levels.
BACKGROUND: Although exposure to house dust mite allergen is a major risk factor for allergic sensitization and asthma, nationwide estimates of dust mite allergen levels in US homes have not been reported. OBJECTIVE: The purpose of this study was to estimate the prevalence of dust mite allergen in beds of US homes and to identify predictors of dust mite allergen concentration. METHODS: Data were obtained from the first National Survey of Lead and Allergens in Housing, a cross-sectional survey of 831 permanently occupied noninstitutional housing units that permitted resident children. Dust mite allergen concentration (Der f 1 plus Der p 1) was determined from a dust sample collected from a bed. The percentages of homes with concentrations at or greater than detection, 2.0 microg/g bed dust, and 10.0 microg/g bed dust were estimated. Independent predictors of allergen concentration were assessed with multivariable linear regression. RESULTS: The percentages of US homes with dust mite allergen concentrations at or greater than detection, 2.0 microg/g, and 10.0 microg/g were 84.2% (SE, 1.73), 46.2% (SE, 2.0), and 24.2% (SE, 2.1), respectively. Independent predictors of higher levels were older homes, non-West census regions, single-family homes, no resident children, lower household income, heating sources other than forced air, musty or mildew odor, and higher bedroom humidity. CONCLUSION: Most US homes have detectable levels of dust mite allergen in a bed. Levels previously associated with allergic sensitization and asthma are common in US bedrooms. Predictors can be used to identify conditions under which homes are more likely to have increased dust mite allergen levels.
Authors: Lindsay Rosenfeld; Ginger L Chew; Rima Rudd; Karen Emmons; Luis Acosta; Matt Perzanowski; Dolores Acevedo-García Journal: J Urban Health Date: 2011-02 Impact factor: 3.671
Authors: Felicia A Rabito; Shahed Iqbal; Elizabeth Holt; L Faye Grimsley; Tareq M S Islam; Susanne K Scott Journal: J Urban Health Date: 2007-11 Impact factor: 3.671
Authors: Päivi M Salo; Samuel J Arbes; Patrick W Crockett; Peter S Thorne; Richard D Cohn; Darryl C Zeldin Journal: J Allergy Clin Immunol Date: 2008-02-06 Impact factor: 10.793
Authors: Jay Portnoy; Jeffrey D Miller; P Brock Williams; Ginger L Chew; J David Miller; Fares Zaitoun; Wanda Phipatanakul; Kevin Kennedy; Charles Barnes; Carl Grimes; Désirée Larenas-Linnemann; James Sublett; David Bernstein; Joann Blessing-Moore; David Khan; David Lang; Richard Nicklas; John Oppenheimer; Christopher Randolph; Diane Schuller; Sheldon Spector; Stephen A Tilles; Dana Wallace Journal: Ann Allergy Asthma Immunol Date: 2013-12 Impact factor: 6.347
Authors: Vijaya B Joshi; Andrea Adamcakova-Dodd; Xuefang Jing; Amaraporn Wongrakpanich; Katherine N Gibson-Corley; Peter S Thorne; Aliasger K Salem Journal: AAPS J Date: 2014-07-01 Impact factor: 4.009
Authors: Jean Curtin-Brosnan; Elizabeth C Matsui; Patrick Breysse; Meredith C McCormack; Nadia N Hansel; Emily S Tonorezos; Peyton A Eggleston; Dann L Williams; Gregory B Diette Journal: Ann Allergy Asthma Immunol Date: 2008-11 Impact factor: 6.347
Authors: C K Jennifer Loo; Richard G Foty; Amanda J Wheeler; J David Miller; Greg Evans; David M Stieb; Sharon D Dell Journal: Int J Environ Res Public Health Date: 2010-08-23 Impact factor: 3.390